Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

EHU049871

Sigma-Aldrich

MISSION® esiRNA

targeting human CD109

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

Quality Level

100

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

TGCTGACTTGGAGAGCAGAACAAGAAGGTGGCATGCAATTCTGGGTGTCATCAGAGTCCAAACTTTCTGACTCCTGGCAGCCACGCTCCCTGGATATTGAAGTTGCAGCCTATGCACTGCTCTCACACTTCTTACAATTTCAGACTTCTGAGGGAATCCCAATTATGAGGTGGCTAAGCAGGCAAAGAAATAGCTTGGGTGGTTTTGCATCTACTCAGGATACCACTGTGGCTTTAAAGGCTCTGTCTGAATTTGCAGCCCTAATGAATACAGAAAGGACAAATATCCAAGTGACCGTGACGGGGCCTAGCTCACCAAGTCCTGTAAAGTTTCTGATTGACACACACAACCGCTTACTCCTTCAGACAGCAGAGCTTGCTGTGGTACAGCCAACGGCAGTTA

Ensembl | human accession no.

ENSG00000156535

NCBI accession no.

NM_133493

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... CD109(135228) , CD109(135228)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
ZDV

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Xue-Tang Mo et al.
British journal of cancer, 123(5), 833-843 (2020-06-09)
CD109 was involved in the tumorigenesis and progression of various cancers via TGF-β1 signalling and STAT3 activation. As CD109 is strongly expressed in cervical squamous cell carcinoma, this study was conducted to investigate its functional characteristics in cervical cancer. CD109
Guijuan Zong et al.
Digestive diseases and sciences, 61(8), 2303-2314 (2016-04-15)
Hepatocellular carcinoma (HCC) accounts for 75-80 % of primary liver cancer, and usually arises after years of liver disease. Thus it is important to understand the molecular mechanisms which drive or mediate the development of HCC. In this work, we examined

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service